Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOPHIST: Sotagliflozin in Heart Failure and Type 1 Diabetes
NCT06435156Phase 2Recruiting
- Sponsor
- University of Dundee
- Start
- Jan 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sotagliflozin in heart failure (HF), sponsored by University of Dundee. Started Jan 2025; status: recruiting.
02
Drugs
sotagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06435156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06435156.